China Pharma Holdings CPHI
NYSE CPHI
$1.03 -0.05 (-4.62%)
At close: Aug 20, 2026 · 1:58 PM UTC

China Pharma Holdings (CPHI) Net Equity Issued and Repurchased (2021)

China Pharma Holdings' (CPHI) quarterly Net Equity Issued and Repurchased came in at $7.3 million in Q4 2021, up 438.26% on a QoQ basis from -$2.2 million in Q3 2021.

China Pharma Holdings (CPHI) Net Equity Issued and Repurchased (2021) Analysis & Trends

China Pharma Holdings (CPHI) has 1 years of Net Equity Issued and Repurchased data on file, last reported at $7.3 million in Q4 2021.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $7.3 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $5.0 million (changed N/A YoY) and the FY2021 annual result came in at $5.0 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased rose to $7.3 million in Q4 2021, from -$2.2 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $7.3 million in Q4 2021 to a low of -$2.2 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 43.94 Bn 42.97 Bn - -
2 Teva Pharmaceutical Industries 42.95 Bn 39.30 Bn 2.15 Bn -
3 Zoetis 31.58 Bn 29.90 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn -
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 700,000.00
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn 84.80 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 China Pharma Holdings 41.74 Mn 41.44 Mn 83,566.00 -

Historic Data

Download Data
DateValue
Dec 31, 2021 7.32 Mn
Dec 31, 2021 7.32 Mn
Sep 30, 2021 -2.16 Mn
Sep 30, 2021 -2.16 Mn
Jun 30, 2021 -301.00
Jun 30, 2021 -301.00
Mar 31, 2021 -154,215.00
Mar 31, 2021 -154,215.00